Delivery Order SPE2DR25D1106-SPE2DR26FJA4U
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Xcopri 100 mg tablets (30-count units) with a ceiling value of $2,357.92. This firm fixed-price delivery order, which has an ultimate completion date of September 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Xcopri 200 mg tablets (30-count packaging) under a firm fixed-price contract valued at $1,684.59. This is a non-set-aside award, indicating the contract was competitively bid. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 4, 2025. This delivery order is issued as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,413.60 on August 25, 2025, for the supply of Xcopri 200 mg tablets (30-count). The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1.77K to AmerisourceBergen Drug Corp on July 9, 2025, for the supply of Xcopri 100 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $1,612.40 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Xcopri 200 mg tablets in quantities of 30. This firm fixed-price delivery order, which is not set-aside designated, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Xcopri 100 mg tablets in a quantity of 30 units, with a contract ceiling value of $2,338.28. This is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,251.04 delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Xcopri 100 mg tablets (30-count package). This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 12, 2025, and represents a child delivery order under AmerisourceBergen's larger prime contract vehicle with DLA. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Xcopri 50 mg tablets (30-count) with a ceiling value of $1,182.13. This firm fixed-price delivery order, set to complete by August 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves no set-aside designation, indicating it was competitively awarded through open competition....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Xcopri 200 mg tablets (30-count units) under a firm fixed-price contract valued at $2,820.90. This is a non-set-aside award, indicating the contract was competitively awarded. The delivery order is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Xcopri 100 mg tablets (30-count units) with a contract ceiling value of $13,696.56. This firm fixed-price delivery order, valued at approximately $13.7K, represents a competitive award with no set-aside designation and is scheduled for completion by November 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJA4UDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Xcopri 100 mg tablets (30-count) valued at $2,733.37 under a firm fixed-price contract. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award carries no set-aside designation and was competitively awarded, with performance to be executed at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of November 21, 2025. The contract is scheduled to conclude on November 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Through its comprehensive IDC vehicle with DLA Troop Support Medical, the company supplies an extensive portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Xcopri, a pharmaceutical product, exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare systems with flexible and reliable medical supply capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 11/20/25 |